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Meniscus is a ﬁbrocartilaginous tissue that has an important role in bio-
mechanics of the knee joint. Fibrochondrocytes and ﬁbroblast-like cells
are the two main cell populations present in the meniscus. Meniscus is
distinguished into two regions: avascular and vascular region. Cellular-
ity varies within the human meniscus, speciﬁcally between avascular
and vascular regions of the meniscus, but also between anterior, medial
and posterior parts. Cellularity is one of the important characteristics
that should be considered in tissue engineering and regenerative medi-
cine strategies. The aim of this study is to calculate the 3D cell density
of human meniscus using histological slides. Meniscus tissues obtained
from donors are prepared into Giemsa stained histological slices with a
thickness of 30 lm. Slices are grouped by their anatomical location into
three parts: anterior, medial and posterior. Cells in the deﬁned areas of
avascular and vascular regions are counted either as ﬁbrochondrocytes
or as non-ﬁbrochondrocytes using a stereomicroscope. 3D cell densities
of different region and parts of the meniscus are estimated by calculat-
ing the number of the cells found in unit volume. The initial results
show that the 3D cell density is around 8000 cells/mm3in vascular part
that is the almost double of the density in avascular part. Chondrocytes
take up more than the half of the total cell amount in avascular part,
and less than the half in the vascular part. This work aims to contribute
to the knowledge of cellularity of human meniscus and facilitates
the development of more efﬁcient strategies for meniscus tissue
engineering. The authors thank the ﬁnancial support of the MultiScale-
Human project (Contract number: MRTN-CT-2011-289897) in the
Marie Curie Actions—Initial Training Networks.
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Tissue engineering is an emerging ﬁeld focused on the development of
novel bioactive multifunctional materials that can be used to replace
damaged and failing tissues. However, these biomaterials often present
several problems such as loss of mechanical and/or biological proper-
ties and adverse immune responses. The use of natural polymers, such
as proteins, provides a promising solution for these drawbacks. With
advances in recombinant DNA technology and biotechnology, it is possi-
ble to design and produce new materials with different features by
combining domains of different proteins in the same fusion protein.
Spider dragline silk proteins have been suggested to have a large poten-
tial for many different biomedical applications due to its outstanding
mechanical properties. In addition, spider silk is also biocompatible,
hypoallergenic and completely biodegradable. Recently, silk copolymers
based on repeats of the consensus sequence of MaSp1 (major ampul-
late spidroin I) from Nephila clavipes (6mer) have been fused with dif-
ferent functional proteins, peptides and protein motifs, showing
promising results [1, 2]. In this project, by exploring the use of recombi-
nant DNA techniques, we have constructed new silk copolymers com-
posed of a structural motif (6mer) fused with functional domains
namely GFOGER (from collagen type I) and FNII (ﬁbronectin domain
II); both are involved in cell adhesion and angiogenesis processes
which are key factors in tissue engineering. Expression and puriﬁcation
of the new chimeric proteins were successfully attained in Escherichia
coli by means of auto-induction media. Furthermore, formic acid can be
explored as a solvent for processing of the aforementioned recombinant
copolymers. Results from the characterization of these biomaterials will
be presented.
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